Jon Wildin has extensive experience in the pharmaceutical industry, having served in various leadership roles at AstraZeneca from 2006 to 2013, including Global Commercial Evaluation Director and Global Brand Director. They have also held positions such as Head of Solid Tumours and Interim VP of Oncology Therapy Area. Jon earned a Doctor of Philosophy (Ph.D.) in Clinical Pharmacology from The University of Manchester and a Bachelor of Pharmacy (B.Pharm.) from King's College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices